Dashboard
Manage Tickers

AMRN AMARIN CORP PLC

Nasdaq www.amarincorp.com


$ 15.20 $ -0.46 (-2.94 %)    

Tuesday, 04-Nov-2025 15:59:54 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 619.26 $ 0.00 (0 %)
DIA $ 471.60 $ 0.00 (0 %)
SPY $ 675.56 $ 0.00 (0 %)
TLT $ 89.52 $ 0.00 (0 %)
GLD $ 366.06 $ 0.00 (0 %)
$ 15.2
$ 15.46
$ 14.55 x 100
$ 15.70 x 100
-- - --
$ 7.08 - $ 20.90
143,261
na
nm
$ 1.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

amarin-to-present-new-data-highlighting-vascepas-cardiovascular-benefits-and-epas-anti-inflammatory-antioxidant-mechanisms-at-aha-2025
Amarin To Present New Data Highlighting VA...
11/03/2025 13:41:34

Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care, today announced it w...

amarin-corp-q3-2025-adj-per-ads-019-up-from-100-yoy-sales-49670m-beat-43099m-estimate
Amarin Corp Q3 2025 Adj per ADS $0.19 Up F...
10/29/2025 11:17:01

Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.19 per share. This is a 119 percent increase over losses of $(1.00)...

earnings-scheduled-for-october-29-2025
Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

earnings-outlook-for-amarin-corp
Earnings Outlook For Amarin Corp
10/28/2025 21:01:31

watching-amarin-shares-move-higher-hearing-zacks-surprise-trader-newsletter-mentions-stock-as-a-buy
Watching Amarin; Shares Move Higher; Heari...
10/24/2025 15:57:37

Core News & Articles
HLS Therapeutics And Amarin To Present IPE...
10/14/2025 12:48:05

HLS Therapeutics Inc. ("HLS" or the "Company") (TSX:HLS), a pharmaceutical company focusing on addressing unmet...

amarin-to-present-icosapent-ethyl-eicosapentaenoic-acid-data-at-canadian-cardiovascular-congress
Amarin To Present Icosapent Ethyl, Eicosap...
10/14/2025 12:06:11

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company commi...

reported-saturday-amarins-reduce-it-analyses-show-icosapent-ethyl-cuts-hospitalizations-by-9-and-lowers-cardiovascular-risk-in-high-risk-patients
Reported Saturday, Amarin's REDUCE-IT Anal...
09/02/2025 07:49:17

2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl as Class IIA Recommended Therapy in High...

reported-sunday-amarin-presents-mechanistic-insights-into-epas-cardiovascular-protection-through-lipoproteina-oxidation-inhibition-and-nlrp3-inflammasome-pathway-modulation
Reported Sunday, Amarin Presents Mechanist...
09/02/2025 07:42:52

amarin-to-present-new-data-on-icosapent-ethyls-cardioprotective-effects-at-esc-2025-highlighting-inflammation-and-oxidation-mechanisms
Amarin To Present New Data On Icosapent Et...
08/25/2025 12:10:55

Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congres...

amarin-corp-q2-adj-eps-004-beats-017-estimate-sales-72740m-beat-53786m-estimate
Amarin Corp Q2 Adj. EPS $0.04 Beats $(0.17...
07/30/2025 11:10:54

Amarin Corp (NASDAQ:AMRN) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.17) b...

Core News & Articles
Earnings Scheduled For July 30, 2025
07/30/2025 08:32:48

amarin-corporation-says-hls-therapeutics-secured-nova-scotia-reimbursement-for-vascepa-expanding-access-to-over-95-of-eligible-patients-in-canada
Amarin Corporation Says HLS Therapeutics S...
07/02/2025 10:33:26

goldman-sachs-maintains-sell-on-amarin-corp-raises-price-target-to-12
Goldman Sachs Maintains Sell on Amarin Cor...
06/25/2025 17:42:27

Goldman Sachs analyst Paul Choi maintains Amarin Corp (NASDAQ:AMRN) with a Sell and raises the price target from $7 to $12.

amarin-shares-surge-after-175m-european-licensing-deal-for-heart-drug-vazkepa
Amarin Shares Surge After $175M European L...
06/24/2025 18:02:32

Amarin Corporation (NASDAQ: AMRN) shares are trading higher Tuesday after the company announced a long-term exclusive license a...

amarin-lands-massive-european-commercialization-deal-for-heart-drug-vazkepa-stock-surges
Amarin Lands Massive European Commercializ...
06/24/2025 17:54:50

Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to impro...

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
06/24/2025 17:06:36

Core News & Articles
Market-Moving News for June 24th
06/24/2025 11:16:06

INM: 102% | InMed shares are trading higher after the company announced preclinical data showing INM-901 reduced neuroinflammat...

amarin-enters-license-and-supply-agreement-with-recordati-to-commercialize-vazkepa-in-europe-amarin-will-receive-25m-upfront-payment-and-milestones-totaling-up-to-150m
Amarin Enters License And Supply Agreement...
06/24/2025 11:03:19

amarin-strikes-175m-deal-with-recordati-to-expand-heart-drug-vazkepa-across-59-european-countries
Amarin Strikes $175M Deal With Recordati t...
06/24/2025 11:02:14

Amarin Corporation (NASDAQ:AMRN) today announced that the Company has entered into an exclusive long-term license and supply ag...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION